Abbott Share Price | Abbott Stock Screener
ABBOTINDIA
Pharmaceuticals
Share Price NSE
₹28005.00
▼
-30.00 (-0.11%)
Share Price BSE
₹28003.45
▼
-76.00 (-0.27%)
As of July 24, 2026, the Abbott share price (NSE: ABBOTINDIA) is ₹28,005.00 on NSE and ₹28,003.45 on BSE, down 0.11% from the previous close, with shares trading between ₹27,650.00 and ₹28,050.00, and a 52-week range of ₹25,180.00–₹35,195.00.
Analyse Abbott stock price data download and track historical price performance.
Use the Abbott stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Abbott Market Cap
₹61,410.50 Cr.
ABBOTINDIA P/E Ratio (TTM)
39.57
Abbott P/B Ratio
12.86
EPS (TTM)
₹730.36
Dividend Yield
2.27%
Debt to Equity
0.04
ABBOTINDIA 52 Week High
₹35195.00
Abbott 52 Week Low
₹25180.00
Operating Margin
27.00%
Profit Margin
21.50%
ABBOTINDIA Revenue (TTM)
₹7,217.00
EBITDA
₹2,180.00
Net Income
₹1,552.00
Total Assets
₹6,502.00
Total Equity
₹4,774.00
Abbott Share Price Chart
Screen Abbott share price with an interactive chart. Analyse ABBOTINDIA price trends and volatility across different timeframes.
Abbott Company Profile - Fundamental Screener
Screen Abbott company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ABBOTINDIA shares.
Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Munir Shaikh
ISIN
INE358A01014
Website
https://www.abbott.co.in
Abbott Balance Sheet Screener
Screen ABBOTINDIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 6,502 | 5,917 | 5,194 | 4,556 | 4,224 | 3,840 | 3,547 | 2,941 | 2,416 | 2,066 |
| Current Assets | 3,771 | 4,763 | 3,246 | 3,025 | 3,853 | 3,487 | 3,205 | 2,761 | 2,266 | 1,893 |
| Fixed Assets | 331 | 336 | 225 | 237 | 271 | 251 | 270 | 105 | 81 | 110 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 251 | 277 | 152 | 161 | 201 | 207 | 224 | 75 | 55 | 47 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4,774 | 4,233 | 3,699 | 3,189 | 2,820 | 2,602 | 2,432 | 2,009 | 1,693 | 1,387 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 4,753 | 4,212 | 3,678 | 3,167 | 2,799 | 2,581 | 2,411 | 1,987 | 1,672 | 1,366 |
Abbott Income Statement Screener - Profit & Revenue Analysis
Screen Abbott income statement and profit fundamentals.
Analyze ABBOTINDIA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Abbott share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,217 | 6,685 | 6,097 | 5,503 | 4,997 | 4,391 | 4,208 | 3,792 | 3,416 | 2,960 | 2,665 | 2,337 |
| Expenses | 5,037 | 4,715 | 4,396 | 4,143 | 3,832 | 3,389 | 3,337 | 3,074 | 2,774 | 2,505 | 2,250 | 1,977 |
| EBITDA | 2,180 | 1,970 | 1,701 | 1,360 | 1,165 | 1,002 | 871 | 718 | 642 | 455 | 415 | 360 |
| Operating Profit % | 27.00% | 26.00% | 25.00% | 23.00% | 22.00% | 21.00% | 18.00% | 16.00% | 16.00% | 14.00% | 14.00% | 13.00% |
| Depreciation | 76 | 72 | 71 | 70 | 66 | 58 | 60 | 17 | 16 | 16 | 14 | 15 |
| Interest | 25 | 11 | 12 | 16 | 19 | 18 | 9 | 2 | 4 | 2 | 3 | 1 |
| Profit Before Tax | 2,079 | 1,887 | 1,618 | 1,274 | 1,080 | 926 | 803 | 699 | 622 | 437 | 398 | 344 |
| Tax | 527 | 473 | 417 | 324 | 281 | 235 | 210 | 249 | 220 | 160 | 143 | 115 |
| Net Profit | 1,552 | 1,414 | 1,201 | 949 | 799 | 691 | 593 | 450 | 401 | 277 | 255 | 229 |
| EPS | 730.36 | 665.62 | 565.28 | 446.80 | 375.87 | 325.04 | 279.04 | 211.93 | 188.81 | 130.19 | 120.12 | 107.75 |
Abbott Cash Flow Screener - Liquidity Fundamentals
Screen ABBOTINDIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,319 | 1,012 | 1,213 | 893 | 948 | 727 | 626 | 499 | 153 | 307 |
| Investing Activities | -371 | 182 | -416 | -148 | -396 | -72 | -401 | -257 | -215 | -155 |
| Financing Activities | -1,066 | -925 | -745 | -639 | -637 | -582 | -217 | -143 | -102 | -90 |
| Net Cash Flow | -118 | 269 | 52 | 107 | -86 | 73 | 8 | 99 | -165 | 62 |
Abbott Shareholding Pattern Screener
See Abbott shareholding pattern with promoter, FII, and DII holdings.
Check Abbott promoter holding and ownership changes for ABBOTINDIA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FII Holding | 0.26% | 0.38% | 0.16% | 0.16% | 0.16% | 0.18% | 0.18% | 0.18% |
| DII Holding | 8.93% | 8.78% | 8.92% | 9.19% | 9.11% | 9.00% | 8.91% | 8.81% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.38% | 13.41% | 13.66% | 13.35% | 13.43% | 13.42% | 13.80% | 13.86% |
| Other Holding | 2.43% | 2.44% | 2.28% | 2.31% | 2.31% | 2.42% | 2.12% | 2.16% |
| Shareholder Count | 75,866 | 78,320 | 69,934 | 67,584 | 71,199 | 75,801 | 69,382 | 71,588 |
Abbott Share Dividend Screener - Share Yield Analysis
Check Abbott dividend history with payout and yield data.
View Abbott dividend details including ex-dates and amounts for ABBOTINDIA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹656.00 | 2.27% |
| 2025-March | ₹475.00 | 1.83% |
| 2024-March | ₹410.00 | 1.33% |
| 2023-March | ₹325.00 | 1.20% |
| 2022-March | ₹275.00 | 1.26% |
| 2021-March | ₹275.00 | 1.55% |
| 2020-March | ₹250.00 | 1.67% |
| 2019-March | ₹65.00 | 0.42% |
| 2018-March | ₹55.00 | 0.75% |
| 2017-March | ₹40.00 | 0.73% |
Abbott Stock Index Membership
See which indices include Abbott stock.
Check ABBOTINDIA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSELVI
BSE INDEX BSEQUI
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MSL400
NIFTY 500
NIFTY HEALTHCARE
NIFTY LARGEMID250
NIFTY M150 QLTY50
NIFTY MIDCAP 150
NIFTY MIDSMALL INDIA CONSUMPTION
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY PHARMA
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
Abbott Market Events Screener - Corporate Actions
Get Abbott corporate actions including splits, bonuses, and buybacks.
Check Abbott stock events that may affect ABBOTINDIA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | Annual General Meeting | NA | 8.40% |
| 2026-07-24 | 2026-07-24 | Dividend | ₹ 131.00 /share | 8.40% |
| 2026-07-24 | 2026-07-24 | Dividend | ₹ 525.00 /share | 8.40% |
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 4.62% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 0.09% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -1.36% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 6.57% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -1.83% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 475.00 /share | 13.94% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 0.67% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | -1.42% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 2.06% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 8.45% |
| 2024-07-19 | 2024-07-19 | Dividend | ₹ 410.00 /share | 10.98% |
| 2023-07-21 | 2023-07-21 | Dividend | ₹ 180.00 /share | 12.85% |
Abbott Competitors Screener - Peer Comparison
Screen ABBOTINDIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 466,191 | 40.50 | 61,674 | 12.69% | 11,565 | 61.52 |
| Divis Laboratories | 196,088 | 76.36 | 11,067 | 13.95% | 2,568 | 73.60 |
| Torrent Pharmaceuticals | 191,454 | 89.58 | 13,886 | 20.34% | 2,138 | 66.10 |
| Cipla | 114,318 | 29.60 | 29,045 | 2.24% | 3,870 | 47.02 |
| Zydus Life Science | 113,332 | 22.00 | 27,658 | 17.64% | 5,026 | 51.92 |
| Lupin | 110,051 | 20.54 | 29,039 | 26.75% | 5,356 | 47.81 |
| Mankind Pharma | 105,095 | 54.21 | 14,636 | 14.85% | 1,938 | 55.85 |
| Dr Reddys Laboratories | 98,725 | 31.02 | 35,059 | 3.90% | 4,158 | 29.50 |
| Aurobindo Pharma | 88,240 | 25.42 | 33,385 | 3.21% | 3,376 | 49.50 |
| Laurus Labs | 85,179 | 95.73 | 6,868 | 22.01% | 890 | 64.23 |
Abbott Company Announcements - News Screener
Screen ABBOTINDIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-23 | Communication Providing The Weblink Including Path Of Annual Report. | - |
| 2026-07-23 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-23 | Annual General Meeting On August 13 2026. | - |
| 2026-07-23 | Reg. 34 (1) Annual Report. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-06-15 | Communication To Shareholders - Intimation About Tax Deduction At Source On Dividend | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-19 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-05-11 | Record Date For Dividend | - |
| 2026-05-11 | Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-11 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-04-30 | Board Meeting Intimation for Considering Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Audit Report Of The Statutory Auditors Thereon And To Recommend Final Dividend For The Financial Year E | - |